Mutation A1298C of methylenetetrahydrofolate reductase: Risk for early coronary disease not associated with hyperhomocysteinemia

American Journal of Medical Genetics

Volumn 101, Issue 1, 2001, Pages 36-39

  Szczeklik, Andrzej ^a   Sanak, Marek ^a   Jankowski, Miłosz ^a   Dropiński, Jerzy ^a   Czachór, Renata ^a   Musiał, Jacek ^a   Axenti, Irena ^b   Twardowska, Magdalena ^a   Brzostek, Tomasz ^a   Tendera, Michał ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Coronary artery disease; Folic acid; Genetics; Homocysteine; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID;

ADULT; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGE OF ONSET; ALLELES; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; FOLIC ACID; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOCYSTEINE; HOMOZYGOTE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; PREVALENCE; RISK FACTORS;

EID: 0035370968     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.1315     Document Type: Article

References (15)

1. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. 1997. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94:3290-3295.
2. Brattström L, Wilcken DEL, Öhrvik J, Brudin L. 1998. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease. The result of meta-analysis. Circulation 98:2520-2526.
3. Domagała TB, Undas A, Libura M, Szczeklik A. 1998. Pathogenesis of vascular disease in hyperhomocysteinemia. J Cardiovasc Risk 5:239-247.
4. Friedman G, Goldschmitdt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H. 1999. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 129:1656-1661.
5. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
6. Mager A, Lalezari S, Shohat T, Birnbaum Y, Adler Y, Magal N, Shohat M. 1999. Methyleneterrahydrofolate reductase genotypes and early-onset coronary artery disease. Circulation 100:2406-2410.
7. Mansoor MA, Svardal AM, Ueland PM. 1992. Determination of the in vivo redox status of cysteine, cysteinylgycine, homocysteine, and glutathione in human plasma. Anal Biochem 200:218-229.
8. Rady PL, Tyring SK, Hudnall SD, Vargas T, Kellner LH, Nitowsky H, Matalon RK. 1999. Methylenetetrahydrofolate reductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. Am J Med Genet 86:380-384.
9. Roff DA, Bentzen P. 1989. The statistical analysis of mitochondrial DNA polymorphisms: X2 and the problem of small samples. Mol Biol Evolution 6:539-545.
10. Scott JM, Weir DG. 1998. Folic acid, homocysteine and one-carbon metabolism: a review of essential biochemistry. J Cardiovasc Risk 5:223-227.
11. Sheehe PR. 1966. Combination of log relative risk in retrospective studies of diseases. J Am Pub Health Nations Health 56:1745-1750.
12. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, Morgan G. 1999. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96:12810-12815.
13. Stegmann K, Ziegler A, Ngo ET, Kohlschmidt N, Schroter B, Ermert A, Koch MC. 1999. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neutral tube defects (NTD). Am J Med Genet 87:23-29.
14. Undas A, Domagała TB, Jankowski M, Szczeklik A. 1999. Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. Thrombosis Res 95:281-288.
15. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ. 1998. A second mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neutral tube defects? Am J Hum Genet 62:1044-1051.